Related Experiment Video

Updated: Jun 19, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

The role of mTORC1 pathway in intestinal tumorigenesis

Teruaki Fujishita1, Masahiro Aoki, Makoto M Taketo

  • 1Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Cell Cycle (Georgetown, Tex.)
|October 27, 2009
PubMed

Insights

The mechanistic target of rapamycin complex 1 (mTORC1) pathway is active in colorectal tumors. Inhibiting this pathway with drugs like RAD001 may offer a new treatment for colorectal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The mechanistic target of rapamycin complex 1 (mTORC1) pathway is crucial in cell growth and metabolism.
  • mTORC1 signaling is dysregulated in various cancers, with inhibitors showing therapeutic promise.
  • The role of mTORC1 in colorectal cancer development is not well understood.

Purpose of the Study:

  • To investigate the involvement of the mTORC1 pathway in colorectal tumorigenesis.
  • To evaluate the efficacy of mTORC1 inhibition in preclinical models of colorectal cancer.

Main Methods:

  • Analysis of mTORC1 pathway activation in Apc mutant mouse intestinal adenomas.
  • Treatment of intestinal polyps with RAD001, an mTORC1 inhibitor.

Main Results:

  • The mTORC1 pathway was found to be activated in intestinal adenomas.
  • Elevated levels of mTOR protein were observed in these tumors.
  • RAD001 treatment significantly suppressed polyp growth in Apc mutant mice.

Conclusions:

  • The mTORC1 pathway plays a significant role in colorectal cancer progression.
  • mTORC1 inhibitors represent a potential therapeutic strategy for colorectal cancer treatment.

More Related Videos

Protocols for Analyzing the Role of Paneth Cells in Regenerating the Murine Intestine using Conditional Cre-lox Mouse Models07:48

Protocols for Analyzing the Role of Paneth Cells in Regenerating the Murine Intestine using Conditional Cre-lox Mouse Models

Published on: November 21, 2015

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...